Protalix BioTherapeutics (PBDA.F) Q4 2024 Earnings

Nov 14Confirmed
Q2 2024
Q3 2024
Q4 2024
-0.06
-0.02
0.02
0.06

Details

Expected EPS
0.05697959999999999
Actual EPS
0.028489799999999996
Surprise EPS
-0.03
Surprise Percent
-50%

Description

⁨Protalix BioTherapeutics⁩ (⁦PBDA.F⁩) has reported earnings of ⁦0.028489799999999996⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts